气泡式鼻塞持续气道正压通气联合氨溴索早期防治早产儿呼吸窘迫综合征疗效研究

doi:10.3877/cma.j.issn.1673-5250.2012.02.015

目的

探讨早期应用气流驱动式(IFD)气泡式鼻塞持续气道正压通气(BNCPAP)联合大剂量氨溴索防治早产儿呼吸窘迫综合征(NRDS)的疗效。

方法

选取2009年10月至2011年9月于本院产科分娩后30 min内转入本科的79例早产儿为研究对象，并按照转入顺序随机分为治疗组(IFD－BNCPAP＋大剂量氨溴索，n＝42)及对照组(常规治疗，n＝37)。观察两组患儿生命体征、NRDS发生率、机械通气(MV)使用率、通气时间、住院时间、MV治疗前及12 h后血气分析、呼吸指数(RI)及氧合指数(OI)、肺动态顺应性(Crs)、呼吸道阻力(R)、压力容量(P－V)曲线斜率及并发症发生率，并对结果进行统计学分析(本研究遵循的程序符合本院人体试验委员会所制定的伦理学标准，得到该委员会批准，分组征得受试对象监护人的知情同意，并与之签署临床研究知情同意书)。

结果

两组患儿NRDS发生率和MV使用率比较，差异有统计学意义(P<0.05)。治疗组通气时间及住院时间较对照组明显减少，差异有统计学意义(P<0.05)。两组MV治疗前及12 h后二氧化碳分压(PaCO₂)、OI及RI比较，差异有统计学意义(P<0.01)，pH值比较，差异无统计学意义(P>0.05)；两组上机24 h及72 h后，Crs，R及P－V曲线斜率比较，差异有统计学意义(P<0.01)。治疗组并发症发生率低于对照组，但差异无统计学意义(P>0.05)。

结论

早期应用IFD－BNCPAP联合大剂量氨溴索可提高肺顺应性，改善肺氧合功能，对NRDS具有良好疗效。

关键词: 早产儿, 呼吸窘迫综合征, 持续气道正压通气, 氨溴索, 预防, 治疗

Objective

To evaluate the effect of infant flow driver bubble nasal continuous positive airway pressure (IFD-BNCPAP) combined with large dose ambroxol in the prevention and treatment on neonatal respiratory distress syndrome(NRDS).

Methods

From October 2009 to September 2011, 79 premature infants who were born within 30 min and sent in department of neonatology were included in the study, and were divided randomly into treatment group(IFD-BNCPAP+ ambroxol, n=42) and control group (regular treatment, n=37). The vital sign, incidence rate of NRDS, usage rate of mechanical ventilation (MV), duration of ventilation and hospitalization, blood gas analysis results, respiratory index (RI), respiratory compliance(Crs), resistance(R) and pressure-volume curve (P-V) slope of curve were observed and statistically analyzed. The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Hospital of Weifang Medical University.Informed consent was obtained from each parents.

Results

There were significant differences in incidence rate of NRDS and usage rate of MV between two groups(P<0.05). The duration of ventilation and hospitalization in treatment group was obviously lower than those in control group(P<0.05). The blood gas analysis results showed that there had significant difference in PaCO₂, RI, Crs, R and P-V slope of curve between two groups(P<0.05). There was no significant difference in incidence rate of complication between two groups(P>0.05).

Conclusions

The IFD-BNCPAP combined with large dose ambroxol on premature infants with NRDS had great effect in early time.This method can effectively improve oxygenation function, meanwhile can prevent and treat NRDS.

Key words: premature infant, respiratory distress syndrome, continuous positive airway pressure, ambroxol, prevention, treatmennt

表1 两组患儿预防效果比较(±s)

Table 1 Comparison of preventive effects between two groups(±s)

组别	n	NRDS发生率[n(%)]	MV使用率[n(%)]	通气时间(h)	住院时间(d)
治疗组	42	6(14.29)	5(11.91)	60.60± 7.89	20.24±2.43
对照组	37	12(32.43)	10(27.03)	96.80±10.14	24.14±2.14
χ²或t	?	3.69	4.34	－6.95	－7.53
P	?	<0.05	<0.05	<0.05	<0.05

表1 两组患儿预防效果比较(±s)

Table 1 Comparison of preventive effects between two groups(±s)

组别	n	NRDS发生率[n(%)]	MV使用率[n(%)]	通气时间(h)	住院时间(d)
治疗组	42	6(14.29)	5(11.91)	60.60± 7.89	20.24±2.43
对照组	37	12(32.43)	10(27.03)	96.80±10.14	24.14±2.14
χ²或t	?	3.69	4.34	－6.95	－7.53
P	?	<0.05	<0.05	<0.05	<0.05

表2 两组机械通气治疗前及12 h后血气分析结果比较(±s)

Table 2 Comparison of blood gas analysis results before and after 12 h of mechanical ventilation treatment between two groups (±s)

组别	PaO₂(mm Hg)		PaCO₂ (mm Hg)		pH值		OI		RI
组别	治疗前	12 h后	治疗前	12 h后	治疗前	12 h后	治疗前	12 h后	治疗前	12 h后
治疗组	60.00±1.01	72.80±1.93	51.00±2.74	45.60±1.14	7.34±0.02	7.38±0.03	113.75±8.24	145.60±3.85	5.23±0.51	4.12±0.13
对照组	53.60±1.27	66.90±1.53	56.90±2.13	51.50±1.58	7.33±0.02	7.37±0.02	93.76±7.36	118.10±10.40	6.28±0.58	5.11±0.50
t	9.82	6.50	－4.61	－7.38	0.11	1.04	4.77	5.63	－3.4	－4.27
P	<0.01	<0.01	<0.01	<0.01	>0.05	>0.05	<0.01	<0.01	<0.01	<0.01

表2 两组机械通气治疗前及12 h后血气分析结果比较(±s)

Table 2 Comparison of blood gas analysis results before and after 12 h of mechanical ventilation treatment between two groups (±s)

组别	PaO₂(mm Hg)		PaCO₂ (mm Hg)		pH值		OI		RI
组别	治疗前	12 h后	治疗前	12 h后	治疗前	12 h后	治疗前	12 h后	治疗前	12 h后
治疗组	60.00±1.01	72.80±1.93	51.00±2.74	45.60±1.14	7.34±0.02	7.38±0.03	113.75±8.24	145.60±3.85	5.23±0.51	4.12±0.13
对照组	53.60±1.27	66.90±1.53	56.90±2.13	51.50±1.58	7.33±0.02	7.37±0.02	93.76±7.36	118.10±10.40	6.28±0.58	5.11±0.50
t	9.82	6.50	－4.61	－7.38	0.11	1.04	4.77	5.63	－3.4	－4.27
P	<0.01	<0.01	<0.01	<0.01	>0.05	>0.05	<0.01	<0.01	<0.01	<0.01

表3 两组患儿相关呼吸力学参数比较(±s)

Table 3 Comparison of respiratory mechanical parameters between two groups(±s)

组别	Crs[mL/(cm H₂O·kg)]		R[cm H₂O/(L·S)]		P－V slope of curve
组别	24 h	72 h	24 h	72 h	24 h	72 h
治疗组	0.44±0.01	0.52±0.02	81.40±1.82	70.60±2.07	1.33±0.03	1.51±0.01
对照组	0.38±0.01	0.47±0.02	88.20±2.15	80.00±2.26	1.28±0.02	1.48±0.02
t	8.74	5.02	－6.05	－7.78	4.22	3.52
P	<0.01	<0.01	<0.01	<0.01	<0.01	<0.01

表3 两组患儿相关呼吸力学参数比较(±s)

Table 3 Comparison of respiratory mechanical parameters between two groups(±s)

组别	Crs[mL/(cm H₂O·kg)]		R[cm H₂O/(L·S)]		P－V slope of curve
组别	24 h	72 h	24 h	72 h	24 h	72 h
治疗组	0.44±0.01	0.52±0.02	81.40±1.82	70.60±2.07	1.33±0.03	1.51±0.01
对照组	0.38±0.01	0.47±0.02	88.20±2.15	80.00±2.26	1.28±0.02	1.48±0.02
t	8.74	5.02	－6.05	－7.78	4.22	3.52
P	<0.01	<0.01	<0.01	<0.01	<0.01	<0.01

1	Diblasi RM. Nasal continuous positive airway pressure (CPAP) for the respiratory care of the newborn infant[J]. Respir Care, 2009, 54(9):1209-1235.
2	Jin HZ, Huang DM, Guan XJ, ed.Practice of neonatology[M]．Beijing：People's Medical Publishing House, 2003，421-427.
3	Ma XL, Xu XF, Chen C, et al. Epidemiology of respiratory distress and the illness severity in late preterm or term infants：A prospective multi－center study[J]. Chin Med J, 2010, 123(20):2776-2780.
4	Morley CJ, Davis PG, Doyle LW, et al. Nasal CPAP or intubation at birth for very preterm infants[J]. N Engl J Med, 2008, 358:700-708.
5	Jegatheesan P, Keller RL, Hawgood S. Early variable－flow nasal continuous positive pressure in infants ≤1000 grams at birth[J]. J Perinatol, 2006, 26:189-196.
6	Malerba M, Ragnoli B. Ambroxol in the 21st century: Pharmacological and clinical update[J]. Expert Opin Drug Metab Toxicol, 2008, 4(8):1119-1129.

[1]	史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(08): 778-784.
[2]	张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[3]	李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4]	陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[5]	刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[6]	刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[7]	袁园园, 岳乐淇, 张华兴, 武艳, 李全海. 间充质干细胞在呼吸系统疾病模型中肺组织分布及治疗机制的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 374-381.
[8]	陈杰, 武明胜, 李一金, 李虎, 向源楚, 荣新奇, 彭健. 低位直肠癌冷冻治疗临床初步分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 494-498.
[9]	国文凯, 纪鹏程, 毕靖茹, 谢院生. IgA 肾病的十种治疗措施[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 327-333.
[10]	帖璇, 苏晓乐, 王利华. 抗中性粒细胞胞质抗体相关性血管炎治疗研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 345-351.
[11]	李茂军, 唐彬秩, 吴青, 阳倩, 梁小明, 邹福兰, 黄蓉, 陈昌辉. 新生儿呼吸窘迫综合征的管理：多国指南/共识及RDS-NExT workshop 共识陈述简介和评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 607-617.
[12]	崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13]	王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14]	张平骥, 徐钰, 李天水, 庞文翼, 符师宁, 张梦圆. 重症患者镇静治疗现状及期望的调查研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 562-567.
[15]	王昌前, 林婷婷, 宁雨露, 王颖杰, 谭文勇. 光免疫治疗在肿瘤领域的临床应用新进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 575-583.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Therapeutic Effect of Bubble Nasal Continuous Positive Airway Pressure Combined With Ambroxol on Neonatal Respiratory Distress Syndrome

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Therapeutic Effect of Bubble Nasal Continuous Positive Airway Pressure Combined With Ambroxol on Neonatal Respiratory Distress Syndrome